NuVasive, Inc. (NUVA)
-NasdaqGS 23.26 
0.33(1.44%) May 17, 4:00PM EDT
| Prev Close: | 22.93 |
|---|
| Open: | 23.03 |
|---|
| Bid: | 16.47 x 100 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 22.38 |
|---|
| Beta: | 1.25 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 23.01 - 23.37 |
|---|
| 52wk Range: | 12.35 - 25.99 |
|---|
| Volume: | 316,525 |
|---|
| Avg Vol (3m): | 411,395 |
|---|
| Market Cap: | 1.03B |
|---|
| P/E (ttm): | 332.29 |
|---|
| EPS (ttm): | 0.07 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- NuVasive initiated with a Buy at WallachBeththeflyonthewall.com(Fri, May 17)
- Coverage initiated on NuVasive by WallachBethBriefing.com(Thu, May 16)
- NuVasive's Management Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript)at Seeking Alpha(Tue, May 14)
- NUVASIVE INC FinancialsEDGAR Online Financials(Tue, May 7)
- NuVasive buys spine implant manufacturer ANCAP(Mon, May 6)
- 3 Earnings Reports That Caught My Attention Last Weekat Motley Fool(Mon, May 6)
- NuVasive acquires ANC in Dayton, Ohio for $4.5Mat theflyonthewall.com(Mon, May 6)
- NuVasive Announces Acquisition of Manufacturing FacilityMarketwired(Mon, May 6)
- HAE Beats on Earnings, Revs in LineZacks(Fri, May 3)
- LIFE Beats Earnings, Margins LowZacks(Fri, May 3)
- Symmetry 1Q Earnings DisappointZacks(Fri, May 3)
- Hanger 1Q Earnings BeatZacks(Thu, May 2)
- Haemonetics Closes Hemerus AcquisitionZacks(Thu, May 2)
- NuVasive(R) Management to Participate in Investor Events in May and June 2013Marketwired(Wed, May 1)
- Earnings Beat at HospiraZacks(Wed, May 1)
Key Statistics
| Forward P/E (1 yr): | 20.23 |
|---|
| P/S (ttm): | 1.61 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.02 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.24 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 1.81 |
|---|
Business Summary
NuVasive, Inc., a medical device company, engages in the design, development, and marketing of minimally disruptive surgical products and procedurally integrated solutions for the spine.
View More